We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KELYB:NASDAQKelly Services, Inc. Analysis

Data as of 2026-04-12 - not real-time

$15.59

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Kelly Services (KELYB) is trading at $15.59, comfortably above its 20‑day SMA of $13.83 and its 50‑day SMA of $15.09, indicating short‑term price strength. The 14‑day RSI sits at 57.8, suggesting neutral‑to‑slightly bullish momentum. A bullish MACD crossover (line = 0.27, signal = ‑0.06) adds further technical support. Current price sits midway between the computed support of $12.10 and resistance of $18.58, leaving upside room. Volume is trending upward, yet daily volume (~4.6 K) is far below the 10‑day average of 50 K, pointing to thin liquidity. The 30‑day volatility of 74% and a computed beta of –2.47 signal a highly erratic price profile.
Fundamentally, the company posted $4.25 B of revenue but suffered an 11.9% YoY decline and a negative profit margin of –5.98%, with trailing EPS of –$7.24. Operating cash flow remains positive at $122 M and free cash flow at $170 M, partially offsetting the earnings shortfall. Balance‑sheet metrics are mixed: cash of $33 M versus debt of $159 M yields a debt‑to‑equity of 16.3, indicating leverage pressure. The stock trades at a price‑to‑book of 0.55 and a price‑to‑sales of 0.13, far below industry averages, while the DCF‑derived fair value of $63.83 suggests substantial upside. A 1.92% dividend yield is being paid despite negative earnings, raising concerns about sustainability. Recent material news about a strategic agreement with Hunt Equity Opportunities and new board appointments could provide a catalyst for operational improvement.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price above short‑term moving averages
  • High volatility and thin trading volume
  • Negative earnings but positive cash flow

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Significant valuation gap (P/B 0.55, DCF fair value $63.8)
  • Leverage concerns (debt‑to‑equity 16.3)
  • Strategic partnership with Hunt Equity Opportunities

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Potential upside to DCF fair value
  • Sustainable operating cash flow despite earnings loss
  • Low price‑to‑sales and price‑to‑book ratios

Key Metrics & Analysis

Financial Health

Revenue Growth-11.90%
Profit Margin-5.98%
ROE-22.98%
ROA1.40%
Debt/Equity16.29
P/B Ratio0.5
Op. Cash Flow$122.6M
Free Cash Flow$170.6M
Industry P/E30.9

Technical Analysis

TrendNeutral
RSI57.8
Support$12.10
Resistance$18.58
MA 20$13.83
MA 50$15.09
MA 200$12.65
MACDBullish
VolumeIncreasing
Fear & Greed Index87.09

Valuation

Fair Value$63.83
GradeUndervalued
TypeValue
Dividend Yield1.92%

Risk Assessment

Beta-2.47
Volatility74.13%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.